Control of oral biofilm formation by an antimicrobial decapeptide

Journal of Dental Research

Volumn 84, Issue 12, 2005, Pages 1172-1177

  Leung, K P ^a   Crowe, T D ^a   Abercrombie, J J ^a   Molina, C M ^a   Bradshaw, C J ^a   Jensen, C L ^a   Luo, Q ^a   Thompson, G A ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Antimicrobial peptide; Dual flow cell; Oral biofilms; Salivary bacteria; Surface active agent

Indexed keywords

ANTIINFECTIVE AGENT; BENZALKONIUM; CHLORHEXIDINE; DEPSIPEPTIDE; GERMANIUM; HYDROXYAPATITE; LYSYL LYSYL VALYL VALYL PHENYLALANYL LYSYL VALYL LYSYL PHENYLALANYL LYSINE; LYSYL-LYSYL-VALYL-VALYL-PHENYLALANYL-LYSYL-VALYL-LYSYL-PHENYLALANYL-LYSINE; SURFACTANT; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BIOFILM; CONFOCAL MICROSCOPY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL VIABILITY; MICROBIOLOGY; PHASE CONTRAST MICROSCOPY; SALIVA;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL ADHESION; BENZALKONIUM COMPOUNDS; BIOFILMS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; DEPSIPEPTIDES; DURAPATITE; GERMANIUM; HUMANS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; MICROSCOPY, INTERFERENCE; SALIVA; SURFACE-ACTIVE AGENTS;

EID: 33644814957     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910508401215     Document Type: Article

References (23)

1. Baker PJ, Coburn RA, Genco RJ, Evans RT (1978). The in vitro inhibition of microbial growth and plaque formation by surfactant drugs. J Periodontal Res 13:474-485.
2. Bakker DP, van der Plaats A, Verkerke GJ, Busscher HJ, van der Mei HC (2003). Comparison of velocity profiles for different flow chamber designs used in studies of microbial adhesion to surfaces. Appl Environ Microbiol 69:6280-6287.
3. Bissell J, Joly S, Johnson GK, Organ CC, Dawson D, McCray PB Jr, et al. (2004). Expression of beta-defensins in gingival health and in periodontal disease. J Oral Pathol Med 33:278-285.
4. Campanac C, Pineau L, Payard A, Baziard-Mouysset G, Roques C (2002). Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 46:1469-1474.
5. Concannon SP, Crowe TD, Abercrombie JJ, Molina CM, Hou P, Sukumaran DK, et al. (2003). Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol 52:1083-1093.
6. Finlay BB, Hancock RE (2004). Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2:497-504.
7. Foster JS, Pan PC, Kolenbrander PE (2004). Effects of antimicrobial agents on oral biofilms in a saliva-conditioned flowcell. Biofilms 1:5-12.
8. Gilbert P, Das J, Foley I (1997). Biofilm susceptibility to antimicrobials. Adv Dent Res 11:160-167.
9. Guggenheim B, Giertsen W, Schüpbach P, Shapiro S (2001). Validation of an in vitro biofilm model of supragingival plaque. J Dent Res 80:363-370.
10. Helmerhorst EJ, Hodgson R, van't Hof W, Veerman EC, Allison C, Nieuw Amerongen AV (1999). The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 78:1245-1250.
11. Herles S, Olsen S, Afflitto J, Gaffar A (1994). Chemostat flow cell system: an in vitro model for the evaluation of antiplaque agents. J Dent Res 73:1748-1755.
12. Koczulla AR, Bals R (2003). Antimicrobial peptides: current status and therapeutic potential. Drugs 63:389-406.
13. Kolenbrander PE, London J (1993). Adhere today, here tomorrow: oral bacterial adherence. J Bacteriol 175:3247-3252.
14. Kolenbrander PE, Palmer RJ Jr (2004). Human oral bacterial biofilms. In: Microbial biofilms. Ghannoum M, O'Toole GA, editors. Washington, DC: ASM press, pp. 85-117.
15. Loesche WJ (1999). The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 10:245-275.
16. Marsh PD, Bradshaw DJ (1995). Dental plaque as a biofilm. J Ind Microbiol 15:169-175.
17. Quirynen M, Brecx M, van Steenberghe D (2000). Biofilms in the oral cavity: impact of surface characteristics. In: Biofilms: recent advances in their study and control. Evans LV, editor. Amsterdam: Harwood Academic Publishers, pp. 167-187.
18. Raj PA, Dentino AR (2002). Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 206:9-18.
19. Shellis RP (1978). A synthetic saliva for cultural studies of dental plaque. Arch Oral Biol 23:485-489.
20. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002). A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555.
21. Stewart PS, Mukherjee PK, Ghannoum MA (2004). Biofilm antimicrobial resistance. In: Microbial biofilms. Ghannoum M, O'Toole GA, editors. Washington, DC: ASM Press, pp. 250-268.
22. Williams MI (1999). Pre-clinical evaluation of plaque control agents: value of in vitro models. In: Oral biofilms and plaque controls. Busscher HJ, Evans LV, editors. Amsterdam: Harwood academic publishers, pp. 261-276.
23. Zasloff M (2002). Antimicrobial peptides of multicellular organisms. Nature 415:389-395.